CAS 261947-38-0

Formel: C27H27F9N2O3

InChl: InChI=1S/C27H27F9N2O3/c1-5-20-12-23(21-11-17(25(28,29)30)6-7-22(21)38(20)24(40)41-14(2)3)37(15(4)39)13-16-8-18(26(31,32)33)10-19(9-16)27(34,35)36/h6-11,14,20,23H,5,12-13H2,1-4H3/t20-,23+/m1/s1

InChI Key: TUPKOWFPVAXQFP-OFNKIYASSA-N

SMILES: CC[C@@H]1C[C@@H](C2=C(N1C(=O)OC(C)C)C=CC(=C2)C(F)(F)F)N(CC3=CC(=CC(=C3)C(F)(F)F)C(F)(F)F)C(=O)C

CP-532623

CAS: 261947-38-0

CP-532623

Formel: C₂₇H₂₇F₉N₂O₃

Reinheit: 99%

Molekulargewicht: 598.5

Ref: 54-PC1028929

CP-532623

CAS: 261947-38-0

Reinheit: 99%

Ref: IN-DA01V54I

CP-532623

CAS: 261947-38-0

CP-532623, a close structural analog of Torcetrapib, is a CETP inhibitor with highly lipophilic properties. It elevates high-density lipoprotein cholesterol.

Formel: C₂₇H₂₇F₉N₂O₃

Reinheit: 98%

Farbe und Form: Solid

Molekulargewicht: 598.5

Ref: TM-T15004

CP-532623

CAS: 261947-38-0

CP-532623 is a protein inhibitor that blocks the activity of the enzyme cholesterol ester transfer protein (CETP). CP-532623 is a member of the class of inhibitors that are soluble, bioconjugates. It has been shown to inhibit CETP in human cancer cell lines and clinical studies have shown that it lowers blood pressure in humans. CP-532623 is not absorbed when taken orally because it is solubilized and not lipid soluble. This drug has been shown to increase serum levels, which may be due to its inhibition of drug absorption.

Formel: C₂₇H₂₇F₉N₂O₃

Reinheit: Min. 95%

Molekulargewicht: 598.5 g/mol

Ref: 3D-LKA94738